| Trial ID: | L3415 |
| Source ID: | NCT00539396
|
| Associated Drug: |
Technosphere Insulin
|
| Title: |
A 3 Month, Randomized, Open Label, Multi-center Study of Technosphere/Insulin Compared to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Receiving Insulin Glargine
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 1
|
| Interventions: |
DRUG: Technosphere Insulin
|
| Outcome Measures: |
Primary: Change in blood glucose following a standard meal, 0-300 minutes | Secondary: Mean change from baseline HbA1c, week 12
|
| Sponsor/Collaborators: |
Sponsor: Mannkind Corporation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
110
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-03
|
| Completion Date: |
2005-12
|
| Results First Posted: |
|
| Last Update Posted: |
2009-10-14
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00539396
|
